Literature DB >> 23201401

SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB.

Chun-Juan Chen1, Yu-Cai Fu, Wei Yu, Wei Wang.   

Abstract

Oxidative stress-mediated cell death in cardiomyocytes reportedly plays an important role in many cardiac pathologies. Our previous report demonstrated that mitochondrial SIRT3 plays an essential role in mediating cell survival in cardiac myocytes, and that resveratrol protects cardiomyocytes from oxidative stress-induced apoptosis by activating SIRT3. However, the exact mechanism by which SIRT3 prevents oxidative stress remains unknown. Here, we show that exposure of H9c2 cells to 50 μM H(2)O(2) for 6h caused a significant increase in cell death and the down-regulation of SIRT3. Reactive oxygen species (ROS)-mediated NF-κB activation was involved in this SIRT3 down-regulation. The SIRT3 activator, resveratrol, which is considered an important antioxidant, protected against H(2)O(2)-induced cell death, whereas the SIRT inhibitor, nicotinamide, enhanced cell death. Moreover, resveratrol negatively regulated H(2)O(2)-induced NF-κB activation, whereas nicotinamide enhanced H(2)O(2)-induced NF-κB activation. We also found that SOD2, Bcl-2 and Bax, the downstream genes of NF-κB, were involved in this pathological process. These results suggest that SIRT3 protects cardiomyocytes exposed to oxidative stress from apoptosis via a mechanism that may involve the NF-κB pathway.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201401     DOI: 10.1016/j.bbrc.2012.11.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

1.  Sirtuin-3 (SIRT3) and the Hallmarks of Cancer.

Authors:  Turki Y Alhazzazi; Pachiyappan Kamarajan; Eric Verdin; Yvonne L Kapila
Journal:  Genes Cancer       Date:  2013-03

Review 2.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

Review 3.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

4.  Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.

Authors:  Guoliang Meng; Jieqiong Liu; Shangmin Liu; Qiuyi Song; Lulu Liu; Liping Xie; Yi Han; Yong Ji
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

5.  Resveratrol plays dual roles in pancreatic cancer cells.

Authors:  Lei Yang; Liang Yang; Wencong Tian; Jing Li; Jie Liu; Mengmeng Zhu; Yan Zhang; Yinan Yang; Fei Liu; Qiong Zhang; Qianqian Liu; Yanna Shen; Zhi Qi
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-07       Impact factor: 4.553

Review 6.  Role of sirtuins in ischemia-reperfusion injury.

Authors:  Eirini Pantazi; Mohamed Amine Zaouali; Mohamed Bejaoui; Emma Folch-Puy; Hassen Ben Abdennebi; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 7.  Post-translational modifications in mitochondria: protein signaling in the powerhouse.

Authors:  Amanda R Stram; R Mark Payne
Journal:  Cell Mol Life Sci       Date:  2016-05-27       Impact factor: 9.261

Review 8.  Roles of SIRT3 in heart failure: from bench to bedside.

Authors:  De-Xing Hu; Xian-Bao Liu; Wen-Chao Song; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

9.  1,3,6,7-Tetrahydroxy-8-prenylxanthone ameliorates inflammatory responses resulting from the paracrine interaction of adipocytes and macrophages.

Authors:  Dan Li; Qianyu Liu; Wen Sun; Xiuping Chen; Ying Wang; Yuxiang Sun; Ligen Lin
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

10.  The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.

Authors:  Philipp Diehl; Daniel S Gaul; Jonas Sogl; Ulrike Flierl; Darren Henstridge; Juergen Pahla; Heiko Bugger; Maximilian Y Emmert; Frank Ruschitzka; Christoph Bode; Thomas F Lüscher; Martin Moser; Christian M Matter; Karlheinz Peter; Stephan Winnik
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.